Chemical Compound
Iopromide; N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methylbenzene-1,3-dicarboxamide; 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl-; 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl- (9CI); Iopromide; Iopromidum; SHL 414C; Ultravist; Ultravist 300; Ultravist 370; ZK 35760
CAS Registry Number
73334-07-3
Primary record
Iopromide; N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methylbenzene-1,3-dicarboxamide; 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl-; 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl- (9CI); Iopromide; Iopromidum; SHL 414C; Ultravist; Ultravist 300; Ultravist 370; ZK 35760
- 库存
- 8,194 克
- 纯度
- 98.4 %
- CAS
- 73334-07-3
化合物标识与属性
- CAS
- 73334-07-3
- PubChem CID
- 3736
- SMILES
- CN(CC(CO)O)C(=O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)NC(=O)COC)I
- Canonical SMILES
- COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I
名称与同义词
- iopromide
- Ultravist
- Iopromidum
- Iopromida
- Proscope
- 73334-07-3
- iopromid
- Ultravist 300
- lopromid
- Ultravist 370
- Clarograf
- Ultrakon
- Ultravist 150
- Ultravist 240
- Iopromide CRS
- Ultravist (TN)
- Proscope (TN)
- Iopromidum [INN-Latin]
- Iopromida [INN-Spanish]
- Ultravist (pharmacy bulk)
- Iopromide (Standard)
- SHL 414C
- IOPROMIDE [INN]
- IOPROMIDE [JAN]
- RefChem:57670
- IOPROMIDE [MI]
- AC1L1GLH
- IOPROMIDE [USAN]
- Prestwick0_000872
- Prestwick1_000872
- Prestwick2_000872
- Prestwick3_000872
- 712BAC33MZ
- GlyTouCan:G18173GU
- IOPROMIDE [VANDF]
- UNII-712BAC33MZ
- DTXSID0023163
- Iopromide [USAN:INN:BAN]
- ZK 35760
- D07GNP
- IOPROMIDE [MART.]
- AC1Q4PC5
- IOPROMIDE [USP-RS]
- IOPROMIDE [WHO-DD]
- C18H24I3N3O8
- DTXCID503163
- CHEMBL1725
- Iopromide (JAN/USP/INN)
- SCHEMBL24546
- BSPBio_000943
- CHEBI:63578
- Iopromide [USAN:BAN:INN]
- MLS002154045
- Iopromide, analytical standard
- EINECS 277-385-9
- N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N1-methylisophthalamide
- SPBio_002864
- DGAIEPBNLOQYER-UHFFFAOYSA-N
- Iopromide [USAN:USP:INN:BAN]
- MFCD00867924
- BPBio1_001039
- orb1308338
- IOPROMIDE [EP IMPURITY]
- IOPROMIDE [ORANGE BOOK]
- IOPROMIDE [EP MONOGRAPH]
- SCHEMBL29632300
- ZK-35760
- HY-B1362R
- SH-L-414C
- Ultravist 300 In Plastic Container
- BRN 7085608
- CID3736
- IOPROMIDE [USP MONOGRAPH]
- V08AB05
- HMS1570P05
- HMS2097P05
- HMS2233O23
- HMS3370M05
- HMS3714P05
- HMS5081F08
- BAY86-4877
- BCP08449
- CID:3736
- G18173GU
- HY-B1362
- MSK10801
- BAY 86-4877
- Tox21_110684
- AC-535
- AR-1K1128
- EBC-23637
- s3207
- AKOS025402129
- magnesium methanide propan-1-ide(1:1:1)
- Tox21_110684_1
- C18-H24-I3-N3-O8
- CCG-220872
- DB09156
- FI35019
- Iopromide for system suitability 1 CRS
- Iopromide for system suitability 2 CRS
- Iopromid 100 microg/mL in Acetonitrile
- NCGC00016923-01
- NCGC00179367-01
- NCGC00179367-03
- AK468747
- AN-15741
- BC200690
- BS-17441
- DA-64476
- I661
- J11.916D
- LS-29729
- SMR001233368
- SID:134222502
- CAS-73334-07-3
- AB00513942
- CS-0013103
- FT-0627283
- NS00000230
- A12801
- D01893
- N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N-methylisophthalamide
- 334I073
- C038192
- EN300-19767813
- SR-01000841262
- 1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-3-N-methylbenzene-1,3-dicarboxamide
- A1204916
- Q4202805
- SR-01000841262-2
- BRD-A72075775-001-10-4
- BRD-A72075775-001-11-2
- n,n'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-n-methylisophthalamide
- Z2681890595
- B0084-301958
- Iopromide, European Pharmacopoeia (EP) Reference Standard
- 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-N-methyl-
- 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-((methoxyacetyl)amino)-N-methyl-2,4,6-triiodo-
- Iopromide, United States Pharmacopeia (USP) Reference Standard
- N,N'-Bis(2,3-Dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl-1,3-benzenedicarboxamide
- N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N1-methylbenzene-1,3-dicarboxamide
- N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N3-methyl-benzene-1,3-dicarboxamide
- Iopromide for system suitability 1, European Pharmacopoeia (EP) Reference Standard
- Iopromide for system suitability 2, European Pharmacopoeia (EP) Reference Standard
- 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl-
- 1189947-73-6
- 277-385-9
- 76341-55-4
- Iopromide; N,N'-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methylbenzene-1,3-dicarboxamide; 1,3-Benzenedicarboxamide, N1,N3-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(2-methoxyacetyl)amino]-N1-methyl-; 1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl- (9CI); Iopromide; Iopromidum; SHL 414C; Ultravist; Ultravist 300; Ultravist 370; ZK 35760
- N,N -Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetylamino)-N-methylisophthalamide
- N,N -Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-[(methoxyacetyl)amino]-N-methyl-1,3-benzenedicarboxamide
- N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-N-methylisophthalamide
- N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-5-{[(methyloxy)acetyl]amino}benzene-1,3-dicarboxamide
- N-(2,3-dihydroxypropyl)-3-((2,3-dihydroxypropyl)(methyl)carbamoyl)-5-((1-hydroxy-2-methoxyethylidene)amino)-2,4,6-triiodobenzene-1-carboximidic acid
- N-(2,3-dihydroxypropyl)-3-[(2,3-dihydroxypropyl)(methyl)carbamoyl]-5-[(1-hydroxy-2-methoxyethylidene)amino]-2,4,6-triiodobenzene-1-carboximidic acid
- N~1~,N~3~-Bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-methoxyacetamido)-N~1~-methylbenzene-1,3-dicarboxamide